Pharma has no shortage of software. Most commercial and safety teams run a patchwork of point tools, each solving one slice of the problem and none talking to the others. The result is a lot of dashboards and very little connected decision-making.
The cost of disconnection
When sales intelligence, resource planning and route optimisation live in separate systems, the hand-offs are manual and slow. A declining-prescription signal in one place never automatically becomes a reallocation decision somewhere else.
What a platform changes
On a shared intelligence layer, the modules compound. Consider one connected decision: Pharos Signal shows declining prescriptions in North India, Pharos Deploy recommends reallocating 12 MRs, and Pharos RouteIQ re-optimises field coverage, three modules, one decision, no manual hand-off.
Why leaders and investors hear the difference
A "Pharma MIS Tool" and a "Route Optimization Tool" sound like features. Pharos Pulse and Pharos RouteIQ, on one platform, sound like infrastructure, because they are. That is the difference between selling outputs and owning the decision layer.
Pharos as the intelligence layer
Pharos brings nine modules across pharmacovigilance, scientific writing and the commercial field force onto one platform, guidance, intelligence, navigation and decision support, from signals to decisions.
Ready to apply this thinking?
Start a pilot project and evaluate Ichelon's quality within one delivery cycle.